Announcement on Achieving Conditions for Lifting Sales Restrictions and Listing of the 3rd Restricted Stock Trading Period under the 2022 Restricted Stock Incentive Plan

About this update from Aurisco Pharmaceutical Co. Ltd. Class A

(605116“Aurisco Pharmaceutical Co., Ltd.”Announcement on Achieving Conditions for Lifting Sales Restrictions and Listing of the 3rd Restricted Stock Trading Period under the 2022 Restricted Stock Incentive Plan)The total number of shares to be listed and circulated this time is 2,066,000; the listing and circulation date is November 7, 2025.The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Aurisco Pharmaceutical Co. Ltd. Class A